Cheers to Non COVID patients as Sir Ganga Ram resumes OPD services

New Delhi: Main Sir Ganga Ram Hospital situated at Sir Ganga Ram Marg which is Non Covid/ Covid Safe  facility resumed  OPD services in a graded manner from Monday (May 11), from 10 am to 4pm. Each doctor will see maximum four patients in one hour. This announcement has brought cheer to non COVID patients desperate to consult doctors for their ailments.

Dr D S Rana, Chairman, Board of Management, Sir Ganga Ram Hospital, said, ‘ Hospital has created proper infra- structure facilities to minimize the spread of Covid 19 especially keeping in mind that nearly 70%Covid positive persons are aymptomatic.

Patients are advised to show their Risk status on  Arogya Setu app, and  appointment details on their mobiles on demand.

Sir Ganga Ram City Hospital , Pusa Road , New Delhi (Affiliated to Main Sir Ganga Ram Hospital, Rajinder Nagar , New Delhi ) is already a Covid-19 hospital  for admitting confirmed /suspected cases of Covid-19 on payment basis at the behest of Delhi Govt. This is a 120 bedded healthcare facility situated on Pusa Road had started admitting COVID patients from 03rd May 2020.

Related Posts

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

Bharat Mandapam witnessed Spectacle of Crazy Innovations by Maker of Ssi Mantra, Best in class Surgical Robot New Delhi: It was a veritable display of innovative potential and prowess of…

On World Health Day ‘CAHO Na Patient Se Pyaar Hai’

Chennai hosts 3 Day International Conference CAHOCON on Patient Safety in Hospitals starting April 10 New Delhi:  Patient safety in hospitals is a global concern, more so in India. It…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

US market to dent India pharma earnings even as domestic growth remains firm

US market to dent India pharma earnings even as domestic growth remains firm

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg